WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C....

17
Dear Colleague: We invite you to join us in Washington, DC, as the Cornea Society hosts World Cornea Congress V at the Grand Hyatt Hotel, April 13–15, 2005. Previous World Cornea Congress meetings have been pivotal events in the subspecialty. The Congress is held every 10 years and is an important career highlight for all special- ists in cornea and external disease, corneal and refractive surgery, and eye banking. Topics to be covered in the 2-day session include corneal wound healing, ocular surface disease, refractive surgery, infection and immunology, keratoplasty, ocular infection and immunology, keratoconus, contact lenses, dystrophies, degenerations, molecular biology of corneal disease, world health, and eye banking. Sessions for free papers and posters are planned, and the program will feature keynote addresses by international leaders in the field. On pages 13–15, you will find the information and forms you need to register for the meeting and reserve a hotel room. Please keep in mind that you must be registered for the meeting to reserve a hotel room. The Grand Hyatt Hotel is located in the heart of Washington’s business and federal districts, just steps from the Washington Convention Center, MCI Center, the White House, and the free monuments and museums of the city. It is also in close proximity to many renowned theaters and restaurants. The hotel has direct underground access to the Metro subway and is located at Metro Center, which makes getting around this world-class city a breeze. Please plan to join us at the Library of Congress on Thursday, April 14, for a reception in the world’s largest library. We also have a special opening session planned for Thursday morning, April 14, honoring many exceptional leaders in the field of corneal and external disease. We look forward to seeing you in April. Edward J. Holland, MD, Co-Director Mark J. Mannis, MD, Co-Director See you in Washington, DC! WCCV 2005: WASHINGTON, DC Cornea Society members and ASCRS members can take advantage of a special reduced rate if they register for both the WCCV and ASCRS Symposium. See details on page 16 or register online at www.corneasociety.org. Cornea Society members and ASCRS members can take advantage of a special reduced rate if they register for both the WCCV and ASCRS Symposium. See details on page 16 or register online at www.corneasociety.org.

Transcript of WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C....

Page 1: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

Dear Colleague:

We invite you to join us in Washington, DC, as the Cornea Society hosts World Cornea

Congress V at the Grand Hyatt Hotel, April 13–15, 2005.

Previous World Cornea Congress meetings have been pivotal events in the subspecialty.

The Congress is held every 10 years and is an important career highlight for all special-

ists in cornea and external disease, corneal and refractive surgery, and eye banking.

Topics to be covered in the 2-day session include corneal wound healing, ocular

surface disease, refractive surgery, infection and immunology, keratoplasty, ocular

infection and immunology, keratoconus, contact lenses, dystrophies, degenerations,

molecular biology of corneal disease, world health, and eye banking. Sessions for free

papers and posters are planned, and the program will feature keynote addresses by

international leaders in the field.

On pages 13–15, you will find the information and forms you need to register for the

meeting and reserve a hotel room. Please keep in mind that you must be registered

for the meeting to reserve a hotel room.

The Grand Hyatt Hotel is located in the heart of Washington’s business and federal

districts, just steps from the Washington Convention Center, MCI Center, the White

House, and the free monuments and museums of the city. It is also in close proximity

to many renowned theaters and restaurants. The hotel has direct underground access

to the Metro subway and is located at Metro Center, which makes getting around this

world-class city a breeze.

Please plan to join us at the Library of Congress on Thursday, April 14, for a reception

in the world’s largest library. We also have a special opening session planned for

Thursday morning, April 14, honoring many exceptional leaders in the field of corneal

and external disease. We look forward to seeing you in April.

Edward J. Holland, MD, Co-Director

Mark J. Mannis, MD, Co-Director

See you in Washington, DC!

W C C V 2 0 0 5 : W A S H I N G T O N , D C

Cornea Society members and ASCRS members can takeadvantage of a special reduced rate if they register forboth the WCCV and ASCRS Symposium. See details onpage 16 or register online at www.corneasociety.org.

Cornea Society members and ASCRS members can takeadvantage of a special reduced rate if they register forboth the WCCV and ASCRS Symposium. See details onpage 16 or register online at www.corneasociety.org.

Page 2: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

1

1 Important Dates

2 Continuing Medical EducationInformation

3 Special Events and Corporate Support

4 Invited Speakers

6 Paper Presentations

9 Scientific Posters

12 Hotel and Travel Information

13 Hotel Reservation Form

14 Hotel Map

15 Registration Information

16 Registration Form

Contents

I M P O R T A N T D A T E S

March7 Deadline for early-bird

registration fee

11 Preregistration deadline toreceive badge in the mail

11 Deadline for registrationcancellation/refund

15 Deadline for hotelreservations

16 Badges mailed topreregistered attendees

April

13 On-site registration opensat Grand Hyatt

4:00–9:00 PM

Speaker check-in opensat Grand Hyatt

4:00–10:00 PM

14 Opening Ceremonyat Grand Hyatt

7:30 AM

Exhibit Hall opens9:30 AM

Library of CongressReception

7:00 PM

15 EyeWorld BreakfastSymposium

6:00 AM

Page 3: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

2

• Better understand and define the roleof pupil size in refractive surgeryoutcomes

Continuing MedicalEducation (CME)This activity has been planned andimplemented in accordance with theEssential Areas and Policies of theAccreditation Council for ContinuingMedical Education (ACCME) through thejoint sponsorship of the AmericanSociety of Cataract and RefractiveSurgery (ASCRS) and The CorneaSociety. ASCRS is accredited by theACCME to provide continuing medicaleducation for physicians and takesresponsibility for the content, quality andscientific integrity of this CME activity.

C O N T I N U I N G M E D I C A L E D U C A T I O N I N F O R M A T I O N

CME CreditThe American Society of Cataract andRefractive Surgery designates thiseducational activity for a maximum of16 Category 1 credits toward the AMAPhysician’s Recognition Award. Eachphysician should claim only the hoursof credit that he/she actually spent inthe activity.

The American Medical Association hasdetermined that physicians not licencedin the US who participate in this CMEactivity are eligible for AMA PRAcategory 1 credit.

Target AudienceThis educational activity is intended forophthalmologists with an interest incorneal and external disease.

Educational ObjectivesAt the conclusion of this program,attendees will be able to:• Increase their understanding of

corneal wound healing• Better understand the evolution of

keratoplasty• Review dystrophies, degenerations,

and molecular genetics• Assess the role of inflammation in

ocular surface disease• Learn the diagnosis and manage-

ment of fungal keratitis• Review the development of global

standards in eye banking

Friday, April 15

Page 4: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

3

LIBRARY OF CONGRESSRECEPTIONApril 14, 7:00–10:00 PM

On Thursday, the Cornea Society will host areception at the Library of Congress. TheLibrary of Congress is more than just aLibrary. With more than 130 million items, itis a museum holding some of the mostfamous documents in history: the rough draftof the Declaration of Independence, Jelly RollMorton’s early compositions, Maya Lin’soriginal drawing of the Vietnam VeteransMemorial, and some of the earliest-knownbaseball cards. The library’s ThomasJefferson Building is a masterpiece of turn-of-the-century Italian Renaissance architecture.

We look forward to seeing you at thereception. Admission to the reception isincluded in the meeting registration fee.

S P E C I A L E V E N T S A N D C O R P O R A T E S U P P O R T

PATRONS

FRIENDS

VISX Santen

ASSOCIATES

AMO

CooperVision

Elsevier, Inc.

Eye Bank Association of America

Eyeonics

Genzyme

Katena Products, Inc.

Lions Eye Bank at Albany

Midwest Eye Bank

CORPORATE SUPPORTThe directors of the World Cornea Congress V Meeting would like to thank the followingcompanies for their support:

EyeWorldBreakfast Symposium

Friday, April 15

Alternative Perspectivesin Ocular Surface Health

Program Chair:Michael Lemp, MD

Registration and breakfast: 6:00 AM

Program: 6:30–7:30 AM

Supported by an unrestrictededucational grant from AlconLaboratories, Inc.

Minnesota Lions Eye Bank

Moria

Northwest Lions Eye Bank

IOP, Inc.

Rumex International

Tissue Banks International

Vision Share

San Diego Eye Bank

Surgical Specialties Corporation

Please visit the Exhibit Hallat the Grand Hyatt

Thursday9:30–10:15 AM

12:00–1:30 PM

3:15–3:45 PM

Friday7:00–8:00 AM

9:30–10:15 AM

12:00–1:30 PM

3:00–4:00 PM

Page 5: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

4

I N V I T E D S P E A K E R S

Thursday, April 14

Biochemistry, Physiology,and Wound Healing1st Morning SessionModerators: Shigeru Kinoshita, MD

Jonathan Lass, MD

KEYNOTE ADDRESS

Molecular Basis for Corneal Transparency:What Have We Learned?John R. Hassell, PhD

PRESENTATIONSGene Expression Patterns in the Normal

Cornea and in DiseaseWinston W.Y. Kao, PhD

Inflammation and Corneal WoundHealing: Latest UnderstandingEric Pearlman, PhD

What In Vivo Confocal MicroscopyHas Taught Us About CornealWound HealingJames V. Jester, PhD

Matrix Metalloproteinases in the Eye:Emerging Roles for MMPsin Corneal PhysiologyM. Elizabeth Fini, PhD

Role of Neuropeptidesin Corneal Wound HealingTeruo Nishida, MD, Dsc

A Tissue-Engineered Cornea:How Close Are We?May Griffith, PhD

Proliferative Capacity of the CornealEndotheliumDavid Hwang, MD

Future of Gene Delivery to the CornealEndotheliumShukti Chakravarti, PhD

Keratoplasty2nd Morning SessionModerators: Christopher Rapuano, MD

Mark Terry, MD

KEYNOTE

Evolution of KeratoplastyPeter R. Laibson, MD

PRESENTATIONS

Emerging Technologies in PKPAlan Sugar, MD

Endothelial Function After PKPJonathan H. Lass, MD

Visual Function After PKPHelene Boisjoly, MD, MPH

Excimer Laser Treatments After PKPEric D. Donnenfeld, MD

Excimer Laser PTK: Indicationsand LimitationsChristopher Rapuano, MD

Anterior Lamellar KeratoplastySheraz Daya, MD

DLEKMark A. Terry, MD

Future Directions in CornealTransplantationJames P. McCulley, MD

World Cornea Healthand Eye Banking1st Afternoon Session

Moderators: Richard Abbott, MDMark J. Mannis, MD

KEYNOTE ADDRESS

Worldwide Initiatives for the Preventionof Corneal BlindnessRubens Belfort, MD, PhD

PRESENTATIONS

World HealthEpidemiology of Corneal Blindness

WorldwideGuallapalli N. Rao, MD

Corneal Blindness from Trachomaand OnchoceriasisLuciene de Sousa, MD

Cultural and Political Barriersto Corneal Donation WorldwideNaoshi Shinozaki

Bacterial and Fungal Keratitisin the Developing World:New Management StrategiesPrashant Garg, MD

Eye BankingDevelopment of Serologic Screening

in Eye BankingDavid Glasser, MD

Disease Transmission Through CornealTransplantationMarian S. Macsai, MD

Current Status of Corneal StorageElcio H. Sato, MD

Development of Global Standardsin Eye BankingPaul J. Dubord, MD, FRCS(C)

Dystrophies, Degenerations,and Molecular Genetics2nd Afternoon Session

Moderators: William Bourne, MDAlan Sugar, MD

KEYNOTE ADDRESSMolecular Genetics of Corneal

DystrophiesElise Heon, MD, FRCS(C)

PRESENTATIONSGenetics of TGF-b1 Corneal Stromal

DystrophiesAnthony J. Aldave, MD

Macular Corneal DystrophyGordon K. Klintworth, MD, PhD

Fuchs’ DystrophyJohn D. Gottsch, MD

Epithelial DystrophiesJames J. Reidy, MD

Schnyder DystrophyJayne S. Weiss, MD

Posterior Polymorphous DystrophyJohn E. Sutphin, MD

Gelatinous Drop-like Corneal DystrophyAkira Murakami, MD

Cornea Gene TherapyGregory S. Schultz, PhD

Friday, April 15

Refractive Surgery1st Morning Session

Moderators: Michael W. Belin, MDR. Doyle Stulting, MD, PhD

KEYNOTE ADDRESS

Role of Biochemical Corneal Modificationin Refractive SurgeryTheo Seiler, MD, PhD

PRESENTATIONS

What Are the Optical Limits to CornealRefractive Surgery?Dimitri T. Azar, MD

Page 6: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

5

I N V I T E D S P E A K E R S

What Are the Physical Limits to CornealRefractive Surgery?R. Doyle Stulting, MD, PhD

Does Pupil Size Really Matter?Steven C. Schallhorn, MD

Custom Ablation—Where Do the BenefitsCome From?Douglas D. Koch, MD

LASIK, PRK, Epi-Delaminators:Is There a Difference?Richard W. Yee, MD

Approaches to Presbyopia SurgicalCorrectionW. Bruce Jackson, MD

Phakic IOLs—What Is an Optimal Design?Stephen Lane, MD

Phakic IOLs—What Are the Long-TermCorneal Effects?Henry F. Edelhauser, PhD

Ocular Surface Disease2nd Morning Session

Moderators: Edward J. Holland, MDKazuo Tsubota, MD

KEYNOTE ADDRESS

Ocular Surface Inflammation: Overviewof the Role of Inflammation in OcularSurface DiseaseStephen C. Pflugfelder, MD

PRESENTATIONS

Classification of Ocular Surface DiseaseMark J. Mannis, MD

Blepharitis: Understanding thePathophysiology and CurrentTreatmentRonald E. Smith, MD

Current and Future Managementof Dry EyeKazuo Tsubota, MD

Surgical Approaches to Primaryand Recurrent PterygiumDonald T.H. Tan, FRCSG, FRCSE,FRCOphth

Ocular Surface Anatomy and Physiologyof Stem CellsRobert Lavker, MD

Ocular Surface Transplantation: CurrentTechniques and OutcomesEdward J. Holland, MD

Ocular Surface Transplantation:Future DirectionsShigeru Kinoshita, MD, PhD

Keratoprosthetic DevicesEduardo Alphonso, MD

Keratoconus and RelatedThinning Disorders1st Afternoon Session

Moderators: Marian S. Macsai, MDJoel Sugar, MD

KEYNOTE ADDRESSLetting the O2 Through: New Technologies

in Contact Lenses for Keratoconus andSafer Extended WearH. Dwight Cavanagh, MD, PhD

PRESENTATIONSBiochemistry and Genetics of Keratoconus

Joel Sugar, MDRefractive Nonkeratoplasty Treatment

for KeratoconusJoseph Colin, MD

Is It Keratoconus or Not?Michael W. Belin, MD

Contact Lenses in Keratoconus:A Treatment or a Cause?Elisabeth J. Cohen, MD

Results of the CLEK StudyKarla Zadnik, OD, PhD

Lamellar Keratoplasty for CornealEctasiasMassimo Busin, MD

Long-Term Outcomes of PenetratingKeratoplasty for KeratoconusDavid C. Musch, PhD, MPH

Therapeutic Crosslinking of CornealCollagen in KeratoconusGary N. Foulks, MD

New Technologyin Cornea, External Disease,and Refractive SurgeryModerators: Woodford Van Meter, MD

George Waring, MD

Obtaining Accurate Tonometry in CornealDiseaseJames Brandt, MD

A-B Scan Ultrasound MeasurementsAfter Corneal SurgeryWarren Hill, MD

Diagnostic Ultra-High-FrequencyUltrasound of the Anterior SegmentCharles Pavlin, MD

Does Wave Scan Analysis HaveApplications Outside RefractiveSurgery?Julian Steven, MD

Clinical Applications of ConfocalMicroscopyMatthew Petroll, PhD

Infection and Immunology2nd Afternoon Session

Moderators: David Glasser, MDThomas Liesegang, MD

KEYNOTE ADDRESSImmunology of Corneal Graft Rejection

Douglas J. Coster, MD

PRESENTATIONSHow Immunology Has Advanced Our

Understanding of Microbial Keratitis:Potential Therapeutic ApplicationsReza Dana, MD, MPH

Antibiotic-Driven Revolution in theManagement of Bacterial Keratitis:Past, Present, and FutureFrancis Mah, MD

Diagnosis and Treatment of New/Emerging Pathogens in MicrobialKeratitisJohn K. Dart, MA, DM, FRCOphth

Cornea and External Eye Infectionsin HIV-Infected PatientsThomas Liesegang, MD

New Perspectives on Herpes Simplex VirusOcular Disease in the Past DecadeYoshikazu Shimomura, MD, PhD

Selecting Antiviral Drugs for CornealDiseasesTodd P. Margolis, MD, PhD

Diagnosis and Management of FungalKeratitisDenise Freitas, MD

Newer Immunosuppressive Drugs:Their Potential Role in the Therapyof Rheumatologic Corneal DisordersRobert B. Nussenblatt, MD

Page 7: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

6

P A P E R P E R S E N T A T I O N S

Thursday, April 14

KERATOPROSTHESIS and STEMCELL TRANSPLANTATION1st Morning Session

Long-Term Outcome in Eyeswith Seoul-Type KeratoprosthesisMee Kum Kim, MD

Artificial Cornea Under DLKSunita Agarwal, MD

AlphaCor:Past 10 Years and Future DirectionsGeoffrey Crawford, MD

AlphaCor: Predicting SuccessfulRetentionCelia Hicks, FRCOphth

Initial Results from the MulticenterBoston Keratoprosthesis Study GroupBrian Zerbe, MD

Clinical Outcome of the DohlmanKeratoprosthesisYing Qian, MD

Functional and Structural GlaucomaEvaluation in Patients with the BostonType 1 KeratoprothesisStephen Spitzer, MD

British Results of Osteo-Odonto-Keratoprosthesis SurgeryBobby Paul, MD

Use of Intraoperative Mitomycin-Cfor Limbal Stem Cell TransplantationMario Di Pascuale, MD

Autologous Fibrin-Cultured LimbalStem Cells in Patients with UnilateralLimbal Stem Cell Deficiency:Preliminary ResultsElisabetta Bohm, MD

Long-Term Follow-up of AutologousCultured Limbal Stem CellTransplantation in Ocular BurnsPaolo Rama, MD

Corneal Reconstruction Using Tissue-Engineered Epithelial Cell SheetsKohji Nishida, MD

Effect of Cultivated Mucosal EpithelialSheet Transplantation on SeverelyInflamed Corneal Stem Cell DeficiencyTsutomu Inatomi, MD

OCULAR SURFACE DISEASE andCONTACT LENSES2nd Morning Session

Superior Pellucid Marginal CornealDegenerationVandhana Jain, MS

New Disease: X-Linked EndothelialCorneal DystrophyWalter Lisch, MD

Topical Mitomycin-C for theManagement of Conjunctival PrimaryAcquired MelanosisJoseph Frucht-Pery, MD

Management of Recurrent OcularSurface Neoplasia After Failed Medicaland Surgical TherapyAnthony Maloof, MD

Pterygium Surgery Using Fibrin Glue:A No-Suture ApproachLuis Mejia, MD

Outcome of 98 Cases of Pterygium/Autograft Surgery Using Fibrin TissueAdhesive Instead of SutureJohn Hovanesian, MD

Comparative Study: ConjunctivolimbalAutograft, Intraoperative Mitomycin-C,and Combined CLA-MMC in TreatingRecurrent PterygiumRicky Law, MD

Comparison of Conjunctival Autograftwith Amniotic MembraneTransplantation for Pterygium Surgery:Long-Term ResultsYonca Aydin Akova, MD

Current Concepts in PterygiumPathogenesisMinas Coroneo, MD

Blepharitis, Meibum:Influence on Ocular Surface DryingJames McCulley, MD

Ocular Complicationsof Gastric Bypass SurgeryW. Barry Lee, MD

Scleral Contact Lenses in theManagement of Ocular SurfaceDisorders After Stevens-Johnsonand Lyell SyndromesMarc Muraine, MD

Effects of Overnight Orthokeratology:Preliminary Results in BrazilIane Stillitano, MD

OSEIRT/Ortho-K as Additional TreatmentAfter Refractive SurgeryIwane Mitsui, MD

REFRACTIVE SURGERY1st Afternoon Session

Nonwavefront Retreatment for HyperopicOvercorrection After Custom CorneaVasudev Kanade, MD

Laser In Situ Keratomileusis in Patientswith Cornea Guttata and Family Historyof Fuchs’ Endothelial DystrophyMichael Feilmeier

Hyperopic LASIK OutcomesUsing the Nidek EC-5000 Excimer Laserwith a 6.0 mm Optical Zoneand 9.0 mm Treatment ZoneGeorge Waring, MD

Corneal Haze After LASEK and PRKAmgad Kotb, MD

Elasticity in LASIK Versus Normaland Ectatic CorneasRaul Suarez, MD

Corneal Ectasia After LASIKJoaquim Murta, MD

Incidence of Post-LASIK Ectasiain Patients with UnidentifiedPreoperative Risk FactorsMajid Moshirfar, MD

Corneal Ectasia Following LASIKin Patients Without ApparentPreoperative Risk FactorsShawn Klein, MD

Page 8: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

7

P A P E R P E R S E N T A T I O N S

Scanning Electron MicroscopyComparison of the Flap SurfaceBetween a Femtosecond Laserand 2 Different MicrokeratomesRamon Naranjo-Tackman, MD

Femtosecond Laser:Parameters for Corneal Surgeryand Ultrastructural StudyJean-Marc Legeais, MD

Comparative Corneal Stromal BedUltrastructure Analysis of Thin and ThickFlaps Using Mechanical andFemtosecond Laser MicrokeratomeDan Tran, MD

Femtosecond Laser: Myths and Truths:Analysis of Our First 200 CasesPankaj Gupta, MD

Use of IntraLase for Ferrara Ring andIntacs Implantation in Keratoconusand LASIK Ectasia TreatmentFrancisco Sanchez Leon, MD

Complications of the Phakic6 Angle-Supported Anterior ChamberIntraocular LensIra Udell, MD

Factors Related to Endothelial CellDensity Loss After Phakic 6H2 IOLImplantation for MyopiaRaymund Angeles, MD

Functional Outcome and PatientSatisfaction After Artisan PhakicImplantation for Correction of MyopiaNayyirih Tahzib, MD

Artisan Toric Lens Implantationfor Correction of Post-KeratoplastyAstigmatismRudy Nuijts, MD

PENETRATING KERATOPLASTY2nd Afternoon Session

Comparison of Final K Readings in TripleProcedures Using Phaco and ECCETechniquesRoger Langston, MD

Long-Term Results of Normotensive,Noncompressive Suturing Techniquefor Penetrating KeratoplastyS. Gregory Smith, MD

Rotating Corneal Autografts:A Case SeriesBruce Noble, FRCS

Lamellar Wound Configurationfor Penetrating KeratoplastyGabriel van Rij, MD

Shaped Penetrating KeratoplastyUsing a Femtosecond LaserRoger Steinert, MD

Intrastromal Ring in PenetratingKeratoplastyJorg Krumeich, MD

Quality of Vision in FunctioningAllografts After Deep Lamellar andPenetrating Corneal TransplantationNavid Ardjomand, MD

Comparison of Laser-Assisted LamellarKeratoplasty and PenetratingKeratoplasty in Visual Recovery andCorneal TopographyNaoyuki Maeda, MD

Outcomes of Penetrating Keratoplastyin Herpetic Eye Disease: Data from theUK Corneal Graft RegistryJohn Males, MD

Lamellar Sclerokeratoplastywith Fibrin GlueEduardo Arenas, MD

Traumatic Wound DehiscenceFollowing Penetrating KeratoplastyLaura Green, MD

Acute Postoperative ComplicationsFollowing Simultaneous PenetratingKeratoplasty and Glaucoma DrainageImplant InsertionJohn Seedor, MD

Outcome of Ahmed Valves in 41Penetrating Keratoplasty Patientswith Refractory GlaucomaPeter Beckingsale

Long-Term Results of PenetratingKeratoplasty with Simultaneous ParsPlana Glaucoma Drainage ImplantsDavid Ritterband, MD

Use of a Lamellar Flap in PatientsRequiring Combined Keratoplasty andCataract Extraction with a Secondary IOLLuis Izquierdo, MD

Penetrating Keratoplasty with ParsPlana Vitrectomy and Ahmed TubeImplantation in Eyes with IntractableGlaucomaLuis Rodriguez, MD

Friday, April 15

INFECTION and IMMUNOLOGY1st Morning Session

NF-κB in Ocular InflammationMichael Stern, PhD

Silicone Punctal Plugs and the OcularMicrobial FloraSarkis Soukiasian, MD

Infectious Keratitis Following LASIK:ASCRS SurveyEric Donnenfeld, MD

Methicillin-Resistant StaphylococcusAureus Infectious Keratitis FollowingRefractive SurgeryMichael Ehrenhaus, MD

Linezolid: Ultimate Answerto MRSA: Corneal Ulcers andEndophthalmitisBalasubramaniam Ilango, FRCS

Efficacy of Intrastromal Corneal Injectionof Natamycin on Experimental FusariumSolani Keratitis in RabbitsAlvio Shiguematsu, MD

HSV-1 DNA in Tears and Salivafrom Normal AdultsHerbert Kaufman, MD

Herpes Virus DNA in Corneas WithoutHistory of HSV Keratitis: RetrospectiveStudy of 387 Recipient CorneasLies Remeijer, PhD

Primary Graft Failure Associated withCulture-Positive Herpes Simplex Virusin 2 Recpients of a Common DonorS. Lance Forstot, MD

Efficacy of Tacrolimus in the Managementof High-Risk Corneal GraftsAnnie Joseph

Safety and Efficacy of TopicalDihematoporphyrin Ester PhotodynamicTherapy for Corneal Neovascularizationin 1-Day and 5-Day RegimensJohn Sheppard, MD

Page 9: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

8

P A P E R P E R S E N T A T I O N S

Cyclosporine A Drug Delivery Systemfor Corneoscleral TransplantationWeiyun Shi, MD

Effect of Donor Age on Corneal SwellingLance Kwok, PhD

Screening for Previous LASIK in Eye-Bank Corneas Using Optical CoherenceTomographyDavid Huang, MD

Digital Slitlamp Images for TelemedicalDiagnosis of Anterior Segment EyeDiseaseSteven Wiffen

BIOCHEMISTRY2nd Morning Session

Corneal Subbasal Nerve Densityin Patients on Glaucoma TherapyKeith Baratz, MD

Unraveling KeratoconusKeith Meek, PhD

Keratocyte Density and StromalTransparency 1 to 25 YearsAfter Penetrating KeratoplastyWilliam Bourne, MD

Immunohistochemical Evaluationof 2 Corneal Buttonswith Post-LASIK KeratectasiaEzra Maguen, MD

Cohesive Tensile Wound Strengthof Human LASIK CorneasIngo Schmack, MD

Corneal Wound-Healing ResponseFollowing Femtosecond Laser andMicrokeratome LASIK FlapsMarcelo Netto, MD

Novel Biodendritic Adhesive forSutureless Ophthalmic Surgeries:In Vivo Studies of CornealLaceration RepairC. Starck Johnson, MD

Wound Healing After Laser-InducedSuturing of the Cornea: An ExperimentalStudy in Animal ModelsRita Mencucci, MD

Topographic Cues That Mimic the NativeBasement Membrane DifferentiallyModulate Corneal Epithelial CellBehaviorsChristopher Murphy, DVM

Effect of Oxygen Concentration on theProliferation of Human CornealEpithelial CellsRyoji Yanai, MD

Use of Platelet Gel to Enhance Healingof Neurotrophic Corneal UlcersBruce Koffler, MD

Corneal Epithelial HomeostasisFollowing Laser In Situ KeratomileusisDipak Parmar, MD

Effect of Arginine-Threonine-ArginineTetramer on the Severity and Incidenceof Ulcers in the Alkali-Injured RabbitCorneaRoswell Pfister, MD

Supression of Fibrotic Responsesby Mycophenolic Acid and Mitomycin-Cin Human Tenon Fibroblasts In VitroAbraham Solomon, MD

Cytochrome c Peroxidase:A New Treatment of Corneal AbrasionsLorenzo Mannucci, MD

LAMELLAR KERATOPLASTY2nd Afternoon Session

Big-Bubble Deep Lamellar KeratoplastyMohammad Anwar, FRCS

Efficacy and Safety of Deep LamellarKeratoplasty Using the Big-BubbleTechnique in Patients with KeratoconusLuigi Fontana, MD

Complications of Deep Anterior LamellarKeratoplastySanjay Mantry, MD

Comparison of Visual Resultsof Maximum Depth Anterior LamellarKeratoplasty with Deep-ALKPin KeratoconusKlaus Teichmann, MD

Objective Optical-Quality comparisonof Penetrating Keratoplasty and DeepAnterior Lamellar KeratoplastyJavier Gaytan-Melicoff, MD

Deep Lamellar Keratoplasty VersusPenetrating Keratoplasty in Keratoconus:Comparison of Vision and AstigmatismResultsAshraf Amayem, MD

Do Intacs Help in Keratoconus?Tarek Ibrahim, MD

Long-Term Follow-Up of Intacsfor Treating KeratoconusShmuel Levartovsky, MD

Functional and Topographic Resultsin Keratoconus Treatment by CombinedRiboflavin-UVA Corneal Crosslinking:Preliminary ReportAldo Caporossi, FRCS

Femtosecond Laser-Assisted PosteriorLamellar KeratoplastyShahzad Mian, MD

Modified Microkeratome-AssistedPosterior Lamellar Keratoplasty

Using a Tissue Adhesive as SealantSamantha Herretes, MD

Endothelial Cell Loss in Deep LamellarEndothelial Keratoplasty TechniquesJ. James Rowsey, MD

Complications After Descemet’sStripping and Endothelial KeratoplastyFrancis Price, MD

Early Postoperative Complications in aPreliminary Series of Deep LamellarEndothelial KeratoplastiesMichael Hyams, MD

Comparison of the Visual OutcomesAfter Manual and Automated DonorKeratectomy in Deep LamellarEndothelial KeratoplastyKenneth Goins, MD

Flap Endokeratoplasty VersusPenetrating Keratoplasty forPseudophakic Bullous KeratopathyMashhoor Alfayez, MD

Page 10: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

9

S C I E N T I F I C P O S T E R S

Thursday, April 14Pain Control and Corticosteroid Avoidance:Key to Successful Treatmentof Acanthamoeba KeratitisArchimedes Lee Agahan, MD

Ahmed Valve for the Correctionof Severe Glaucoma Secondaryto Acanthamoeba KeratitisTaly Ajwelsztain, MD

Immunogold Localization of Keratan Sulfatein Keratoconus CorneaSaeed Akhtar, PhD

Th1/Th2 Cytokine Levels in the Tear Fluidof Patients with Herpetic KeratitisHiroko Araki, MD

Determine Prognosis in KeratoconusPenny Asbell, MD

Results of Penetrating Keratoplastyin Quiet Eyes After Acanthamoeba KeratitisShady Awwad, MD

Pachymetry in Keratoconus Patients:Comparison at Different Stages andin a Case-Control GroupStefano Baiocchi, PhD

Keratoconus Evaluation Using In VivoConfocal MicroscopyStefano Benedetti, MD

Nocardia Keratitis:A Clinicomicrobiological ReviewSanghamitra Burman, MD

Microkeratome-Assisted TherapeuticKeratoplasty for the Surgical Treatmentof Granular Corneal DystrophyMassimo Busin, MD

Demographics of Corneal Transplantationin Canada: Survey of Corneal TransplantSurgeons and Eye BanksKathy Cao

Frequency 55 Multifocal Contact Lens:Clinical StudyGirish Chandra, MD

3 Cases of Latanoprost-Associated HerpesSimplex KeratitisYoun Joo Choi, MD

Effect of Inhibition of Angiogenesis andLymphangiogenesis After Keratoplastyon Corneal Graft SurvivalClaus Cursiefen, MD

Cataract Surgery Following Deep LamellarKeratoplastySeika Den, MD

Indications for Keratoplasty, 2000–2004Dariusz Dobrowolski, MD

Intraocular Lens Power Calculationin Keratoconus Patients Using TopographyOver Contact LensFabio Dornelles, MD

Indications for Penetrating Keratoplastyin Canada, 1996–2004Stephen Dorrepaal

Wavefront Analysis and Its Correlationwith Refraction and Corneal Topographyin Patients Having Penetrating KeratoplastyAdalia Dourado, MD

Corneal Regraft Using Blood-Typed TissueRichard Eiferman, MD

Evaluation of Corneal Graft Tissue by SlitlampDuring the Preservation PeriodRoberta Farias, MD

Diagnosis of Epithelial IngrowthAfter Penetrating Keratoplastywith Confocal MicroscopyAdriana Forseto, MD

Safety Comparison of Intacsfor Keratoconus Versus for MyopiaBradley Fouraker, MD

Neurotrophic Keratitis in ChildrenNibaran Gangopadhyay, MS

Study of Corneal Transplantation in Chinafrom the Perspective of Corneal DonorsProvided by Eye BankHuaqing Gong, MD

Deep Anterior Lamellar Keratoplasty VsPenetrating Keratoplasty: A ProspectiveRandomized Clinical TrialHassan Hashemi, MD

Fluoroquinolones In Vitro Activity AgainstOcular IsolatesAna Luisa Höfling-Lima, MD

Partial Tectonic Keratoplasty for Terrien’sMarginal DegenerationYoung-Hoon Hwang

Ferrara Intrastromal Corneal Ringsfor KeratoconusLuis Izquierdo Jr, MD

Use of Intravenous Immunoglobulin Therapy inthe Treatment of Ocular Cicatricial PemphigoidSaurabh Jain

Use of Ultrasound Biomicroscopyin the Evaluation of Repair of Descemet’sMembrane DetachmentsBennie Jeng MD

What Is the Ideal Donor Cornea ScleralSkirt Size for Successful Use in ArtificialAnterior Chambers?Thomas John, MD

Preparation of Donor Lamellar Tissue for DeepLamellar Endothelial Keratoplasty Using anArtificial Anterior Chamber SystemPaul Kang, MD

Donor Cornea Endothelial Cell DamageAssociated with Debris in the Storage MediaStephen Kaufman, MD

Efficacy of Tear-Bearing Rigid Gas-PermeableContact Lens in Contact-Lens-IntolerantPatientsMan Soo Kim, MD

Case of Recalcitrant Aspergillus Keratitisand Endophthalmitis Treated with Caspofunginand VoriconazoleCarina Koppen, MD

Femtosecond Laser in Sutureless AnteriorLamellar KeratoplastyAaleya Koreishi, MD

Does Diabetes Affect Progressionof Keratoconus?Irene Kuo, MD

Best Antibiotic for the Treatment of Group BStreptococcus Keratitis?Jeffrey Kurilec, MD

Topical Interferon a2b in the Treatmentof Recalcitrant Ocular Surface SquamousNeoplasiaGraham Lee, MD

Preliminary Reports of Feasibility of PorcineCornea as XenograftJae Lim Lee, MD

Peripheral Ulcerative Keratitisand Hidradenitis SuppurativaMuneera Mahmood, MD

Automated Lamellar Therapeutic KeratoplastyNubia Cristina Maia, MD

Lamellar Keratoplasty and Custom LASEKin the Management of Keratoconus: NovelAlgorithim ApproachMariane Mellem Kairala, MD

Role of Confocal Microscopyin Acanthamoeba KeratitisEliane Nakano, MD

Risk Factors for Endothelial Graft Rejection:Long-Term Results of a ProspectiveNormal-Risk Keratoplasty StudyNhung Nguyen, MD

SEB Combined with IL-1ra Prolong Survivalof Rat High-Risk Corneal AllograftsZhiqiang Pan, PhD

Microkeratome-Assisted Posterior LamellarKeratoplasty Results in 3 CasesAnand Parthasarathy, MS

Use of Protopic to Prevent Rejectionin High-Risk Penetrating Keratoplastiesand in Steroid RespondersAnuradha Prasad, MD

Evaluation of the Severity of Herpes SimplexVirus Keratitis in Atopic Patients:Preliminary ResultsRenata Rezende, MD

Refractive and Topographic Outcomeof Cornea Triple ProcedureMarco Polo Ribeiro, MD

Page 11: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

10

S C I E N T I F I C P O S T E R S

Safer Method of Full-Thickness KeratoplastyGeorge Rosenwasser, MD

Postoperative Outcomes of AutomatedLamellar Therapeutic KeratoplastyKeiko Sakatani, MD

Microbiological Profile of Donor Corneasin Northern IndiaGita Satpathy, MD

Visual Outcomes in Deep Lamellar EndothelialKeratoplasty With and Without an AutomatedMicrokeratome for Donor HarvestRobert Schultze, MD

Patterns of Amniotic Membrane Integration inHuman Corneas: Histology and UltrastructureBerthold Seitz, MD

Assessment of the BiomechanicalProperties of the Cornea Using the ReichartOcular Response Analyzer in Normal andKeratoconic EyesSunil Shah, MD

Acute Corneal Hydrops Ttreatedby Intracameral Injectionof Perfluoropropane GasSushmita Shah

Ultrastructural Detection of ChlamydiaInclusions in Conjunctival Epithelial Cells fromPatients with Chronic Follicular ConjunctivitisJanine Smith, MD

Treatment of Corneal Endothelial Rejectionwith Intracameral TriamcinoloneLuciene Sousa, MD

AlphaCor: Evolution in Surgical TechniqueR. Doyle Stulting, MD

New Donor Cornea Harvesting Techniquefor Posterior Lamellar KeratoplastyOlan Suwan-apichon, MD

Outcome of Dexamethasone-Pulse Therapyfor Treatment of Endothelial Graft RejectionRadhika Tandon, MD

High-Order Aberrations with Myopic SoftContact LensesBernard Tinio, MD

Meaning of Staphylococcus EpidermidisResiding on Ocular SurfaceMayumi Ueta, MD

Clinical and Demographic Features andOutcome of Endothelial Graft RrejectionRasik Vajpayee, FRCSE

Unilateral Keratoconus: Incidence andTopographic AnalysisRui Hua Wei, MD

Keratoplasty in Silicon Oil KeratopathyEdward Wylegala, PhD

Therapeutic Effect of Penetrating Keratoplastyon Fungal Keratitis with Corneal PerforationLixin Xie, MD

Lipid Raft-Mediated PseudomonasInternalization in Contact Lens-Wearing Eyesand Cultured Human Corneal Epithelial CellsNaoka Yamamoto, MS

Effects of Prolonged Low-Dk RGP Lens Wearor Eyelid Closure-Induced Hypoxiaon Rabbit CorneaNobutaka Yamamoto, MS

Patterns in the Microbiological Analysisof Infectious Keratitis, 1997–2002David Yeh, MD

Infectious Keratitis After OvernightOrthokeratology in CanadaNatasha Yepes, MD

Keratometric Apex Vs Thinnest PachymetryLocation in Keratoconus Patients

Using a Scheimpflug Photography SystemDavid Zadok, MD

Friday, April 15

New Technique for MechanicallyCharacterizing Keratocytes in CornealTissue EngineeringMark Ahearn

Intraocular Lens Power Calculation in Eyeswith Myopic Refractive SurgeryCarlos Arce, MD

Malignant Melanoma of Corneal LimbusItalo Astudillo Munoz, MD

Pediatric Acne Rosacea: Long-Term Treatmentwith Oral ErythromycinYonca Aydin Akova, MD

Use of Intraoperative Mitomycin-C During PTKfor Anterior Corneal PathologyBrandon Ayres, MD

Comparison of Toxicity of FluoroquinolonesUsing Conjunctival and Corneal Cells in VitroAlejandro Babayán, MD

From Purkinje to WavefrontHector Barajas, MD

Corneal Keloid: Clinical, Surgical, andHistopathological CharacteristicsTiago Bisol, MD

Mapping the Structure of the Human Cornea:Implications for Ocular SurgeryCraig Boote, PhD

Effect of Mitomycin-C on the Expressionof Inflammatory Cytokines of Porcine CornealFibroblastsShu-Wen Chang, MD

Inhibitory Effect of Antibody to ±vb5in Corneal AngiogenesisSung Kun Chung, MD

Tarso-Conjunctival Pedicle Flap for theTreatment of Severe Scleral MeltRichard Davidson, MD

Diffuse Lamellar Keratitis After AbortedFemtosecond Laser Flap Creation for Laserin Situ KeratomileusisJohn DeStafeno, MD

Levels of P63 Nuclear Protein as Predictorsof Limbal Cell StemnessSeth Epstein, MD

Recovery of Corneal Subbasal Nerve DensityAfter LASIK and PRKJay Erie, MD

Modified Osteo-Odonto-Keratoprosthesis:Long-Term Results in Dry EyeGiancarlo Falcinelli, MD

Prevalence of Conjunctivochalasis in Patientswith Immune Thyroid DiseaseSandra Fiorentini, MD

Topographic Changes Related to DecentrationSandrine Hick, MD

Age-Related Changes in Ocular SurfaceSensitivity and Tear Secretion Detectedby Onion Lacrimatory FactorHisayo Higashihara, MD

AlphaCor in Patients with Severe OcularSurface DiseaseEdward Holland, MD

Multifocal Phototherapeutic Keratectomyfor the Treatment of Perisistent EpithelialDefectSeung Woo Hong, MD

Comparison of Corneal AsphericityAfter Custom LASIK with the NAVEXand Zyoptix SystemsMitsutoshi Ito, MD

Pupil Diameters in Refractive Surgery MattersJuan Carlos Izquierdo, MD

Quantifying Corneal Biomechanical ChangesFollowing Microkeratome IncisionsPhilip Jaycock, MD

Relationship Between Dry-Eye Syndromeand Hormone Replacement Therapy inPostmenopausal WomenSung Chul Kim

Management of Ocular Graft Versus HostDisease with PseudomembranousConjunctivitis: A Paradigm ShiftStella Kim, MD

Two-Year Follow-up of Flap: LASIK in Myopiawith Insufficient Corneal ThicknessJae-Ho Kim, MD

In Vivo Findings of Bulbar/PalpebralConjunctiva and Presumed Meibomian Glandby Laser Confocal MicroscopyAkira Kobayashi, MD

Page 12: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

11

S C I E N T I F I C P O S T E R S

Pterygium Surgery: Outcomes Using a FreeConjunctival Autograft and TriamcinoloneSai Kolli

Significance of Dark-Area Observationfor the Diagnosis of Nontraumatic RecurrentCorneal ErosionAoi Komuro

Conjunctival Sac Forming Ring for RecurrentPterygium with SymblepharonNaoki Kumagai, MD

Gene Expression Profiles in Primaryand Recurrent PterygiaChuan-Hui Kuo

Heterogeneity of Ocular Surface Diseasein Patients with Ectodermal DysplasiaShree Kurup, MD

HLA-Matched Living-Related ConjunctivalLimbal Allograft for Bilateral Ocular SurfaceDisorders: Long-Term ResultsSérgio Kwitko, MD

Change in Corneal Sensitivity, Nerve Fibers,and Keratocytes After LASIK and LASEKSeung Jae Lee

Effect of Soluble Lumican GlycoproteinPurified from Human Amniotic Membraneon Corneal Epithelial Wound HealingChia-Yang Liu, FRCS

Mininvasive Autologous LimbalTransplantation with Fibrin Gel to Promotein Vivo Expansion of Limbal EpitheliumClaudio Macaluso, MD

Bilateral Inferior Corneal Pseudopterygiumin 2 Children with Kabuki SyndromeArie Marcovich, MD

Amniotic Membrane Transplantationfor Bullous Keratopathy and TrophicCorneal UlcersDiane Marinho, MD

Immunohistochemistry of TransmembraneTNF in Vascularized Human CorneasDaniel Miller, MD

Corneal Thickness in Healthy Lowlandersat High AltitudeDaniel Morris

Results of Scleral Allografting on ScleralNecrosisYoon-Soo Na, MD

Long-Term Follow-up of Intracorneal RingImplantation for the Correction of MyopiaHuma Naikoo, MD

Optical Coherence Tomography Imagingof Corneal Flaps Created with theIntraLase FS LaserJean-Luc Nguyen-Khoa, MD

Amniotic Membrane Transplantin Children with Symblepharonand Massive Corneal PannusKen Nischal, FRCS

Cutaneous Sensitivity to Inhalant Allergensas a Marker of Severity of VernalKeratoconjunctivitisLauro Oliveira

Descriptive Conjunctival and Nasal ImpressionCytology in Vernal ConjunctivitisAdália Oliveira, MD

Efficacy of Cyclosporine 0.05 Eyedropsin the Treatment of Limbal AllergicKeratoconjunctivitisTatsuya Onguchi, MD

Dehydrated Human Amniotic MembraneAllograft for Corneal PerforationsFernando Peniche, MD

X-Ray Scattering Investigation of CornealStructure in Mimecan-Deficient MiceAndrew Quantock, PhD

Pterygium Surgery: Fibrin Glue Versus VicrylSutures for Conjunctival ClosureAvisar Rahamim, PhD

Modified Chondroitin Sulfate AldehydeAdhesive for Sealing Corneal IncisionsJohann Michael Reyes, MD

Evaluation of Central Cloudy CornealDystrophy with In Vivo Confocal MicroscopyNicola Rosa, MD

Effect of Topical Detoxifying Enzyme,Cytochrome c Peroxidase, on CornealReepithelialization After PRKLucia Scorlli, MD

Wavefront Custom Corneal AblationUsing z100 Zyoptix PlatformNorton Severo, MD

Safety and Efficacy of LASIK after RKNaazli Shaikh, MD

Ocular Surface Reconstruction for SevereSymblepharon Resulting from Eye BurnsWeiyun Shi, MD

Clinical Features of Japanese OcularCicatricial PemphigoidMikiko Shimabukuro, MD

Comparison of IOP measurementsby Reichert’s ORA, Pascal Dynamic ContourTonometry, and Goldmann ApplanationTonometry Corrected for CCTMitsugu Shimmyo, MD

In Vivo Noncontact Confocal Microscopyof the Human Tear Film and Ocular SurfaceMichael Smolek, PhD

Photorefractive Keratectomy with AdjunctiveMitomycin-C for the Management of RefractiveErrors Following Penetrating KeratoplastyRenee Solomon, MD

Modulation of Corneal InflammatoryMediators After Alkali Injury by Thymosin 24Gabriel Sosne, MD

Allelic Heterogeneity in CHST6 Gene-Associated Macular Corneal DystrophyMittanamalli Sridhar, MD

In Vivo Confocal Microscopy of a Familywith Posterior Polymorphous Corneal DystrophySathish Srinivasan, MD

Dry Eye in Rheumatoid Arthritis: ConjunctivalHistopathology Study After Propylene Glycol,Polyethylene Glycol 400, and HPGuarTreatmentsCrisanti Stangogiannis-Druya, MD

Corneal Findings of Early-Onset GVHDin 2 CasesYoshinori Takahashi, MD

Ocular Hysteresis in Eyes with PenetratingKeratoplasty and in Normal Subjectsby the Ocular Response AnalyzerKatya Tambe, FRCSE

Bilateral Stromal Opacity of the Corneawith Clear Peripheral MarginKlaus Teichmann, MD

Mesenchymal Stem-Cell-Like Characteristicsof Corneal KeratocytesKong Then, FRCSE

Diamond Burr Polishing of Bowman’sMembrane in the Treatment of DecreasedVision Associated with Anterior BasementMembrane DystrophyPatrick Tzelikis, MD

Results of LADAR Wave-Guided LASEKChien Hsun Wang

Anti-Alpha-Fodrin Antibodies in Tear Fluid,Saliva, and Serum Samples of Patientswith Primary Sjogren’s SyndromeSule Yavuz, MD

Implication of Grading Tear-Film Lipid LayerSpread as the Dry-Eye ExaminationNorihiko Yokoi, MD

Early Results of Combined ConjunctivalRotational Autograft and Mitomycin-Cin the Management of Primary PterygiumAlvin Young, FRCS

Sjogren-Like Syndrome After Bone MarrowTransplantationPanida (Kosrirukvo) Goseyarakwong, MD

Page 13: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

12

Hotel ReservationsThe WCCV has designated Laser Registrationas the official housing management companyfor the meeting. Laser Registration providesfull housing and registration through WCCVMeeting Services. Reservations can be madeonline, by fax, or by mail.

Agents are available to answer questionsMonday–Friday, 8:30 AM to 6:00 PM EST.

Domestic: (866) 614-5502International: (514) 798-1932E-mail: [email protected]

Hotel AcknowledgmentsAcknowledgments will be mailed to you within72 hours of receiving your room reservation.You will receive final confirmation of yourroom reservation no later than 2 weeks afterthe cutoff date of March 15, 2005, or sooner.

Please note: Because hotel rooms areavailable via the Internet, WCCV MeetingServices has not blocked the same number ofrooms as in the past. We encourage you tomake hotel reservations early.

Reservation DeadlineThe deadline for reservations is March 15,2005. Room rates are guaranteed providedrooms are available at your chosen hotel.After the deadline, WCCV Meeting Serviceswill make every attempt to locate rooms atofficial hotels, but it cannot guarantee ratesor availability.

Please note: The Internet has had a greatimpact on the way we travel and do business.Nevertheless, WCCV has succeeded innegotiating a special but limited-availabilityroom rate with Washington DC hotels for the2005 World Cornea Congress V. We urge youto act now to secure your accommodationsthrough the WCCV housing agent.

CancellationsHotel room reservations may be canceledthrough the WCCV Meeting Services withoutpenalty until March 15, 2005. After that date,cancellations must be made directly with thehotel.

If reservations are canceled within 72 hoursof your arrival date, the hotel will chargeyou for the entire stay.

TravelWCCV has negotiated discounted rates fortravel to and from the meeting. Using thefollowing reference codes guarantees thespecial fares several days before and after themeeting dates. Please contact your travelagent or the service provider directly to makeyour travel arrangements.

Am. Airlines A8645AE (800) 433-1790

Avis D005466 (800) 331-1600

Budget U064144 (800) 772-3773

United Airlines 530CC (800) 521-4041

U.S. Airways 86683199 (877) 874-7687

Individuals attending both the WorldCornea Congress V Meeting and theASCRS•ASOA Symposium and Con-gress should make only one hotelreservation for both meetings.

ImportantTo attend the World

Cornea Congress V, you mustcomplete a registration form.

You must register for theWorld Cornea Congress V to

reserve a hotel room.

WCCV Official Hotels*DISTANCE TO

RATES CONVENTION ROOM HEALTH HOTEL SINGLE DOUBLE CENTER SERVICE POOL CLUB RESTAURANTBeacon Hotel and Corp. Qtrs. $191.00 $211.00 7 Blocks Yes Yes Yes YesComfort Inn Convention Center $139.00 $139.00 3 Blocks Yes No Yes NoFairmont Washington DC $249.00 $249.00 18-20 Blocks Yes Yes Yes YesFour Points/Sheraton $202.00 $202.00 3 Blocks Yes Yes Yes YesGrand Hyatt Washington $270.00 $295.00 3 Blocks Yes Yes Yes YesHamilton Crowne Plaza $199.00 $199.00 5 Blocks Yes No Yes YesHampton Inn Convention Center $179.00 $189.00 2 Blocks No Yes Yes NoHay-Adams Hotel $325.00 $325.00 9 Blocks Yes No No YesHenley Park Hotel $195.00 $215.00 1 Block Yes No Yes YesHoliday Inn Downtown $169.00 $179.00 4 Blocks Yes No Yes YesHotel Helix $199.00 $199.00 7 Blocks Yes No Yes YesJW Marriott $221.00 $231.00 6 Blocks Yes Yes Yes YesThe Madison Hotel $271.00 $271.00 6 Blocks Yes No Yes YesMarriott at Metro Center $233.00 $243.00 4 Blocks Yes Yes Yes YesMorrison-Clark Inn $195.00 $215.00 1 Block Yes No Yes YesRenaissance Mayflower $209.00 $209.00 10 Blocks Yes Yes Yes YesRenaissance Washington DC $249.00 $269.00 2 Blocks Yes Yes Yes YesRitz Carlton $325.00 $325.00 16 Blocks Yes Yes Yes YesSt. Regis Washington DC $325.00 $325.00 8 Blocks Yes Yes Yes YesWashington Plaza $172.00 $172.00 4 Blocks Yes Yes Yes YesWashington Terrace Hotel $189.00 $189.00 10 Blocks Yes No Yes YesWyndham Washington DC $212.00 $212.00 5 Blocks Yes Yes Yes Yes

Some properties have limited room service and restaurant facilities; please contact individual properties forfurther information.NOTE: There is a subsidy included in hotel rates to offset event costs.

H O T E L A N D T R A V E L I N F O R M A T I O N

*Please go to www.one-stop-registration.com/ascrs for updated hotel information.

Page 14: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

13

World Cornea Congress V • April 13–15, 2005 • Washington, DC, USAType or Print (Duplicate names will not be accepted)

LAST/FAMILY NAME FIRST NAMEMI DEGREE

PRACTICE NAME

BUSINESS MAILING ADDRESS

CITY STATE ZIP COUNTRY

BUSINESS TELEPHONE (International attendees, please include city and country code for phone and fax) Facsimile (Mandatory)

E-MAIL ADDRESS

By signing this form, I acknowledge the policies stated on page 12, including the cancellationpolicy. Please read all hotel information prior to filling out and submitting form to WCCV MeetingServices. Keep a copy of this form. Use one form per room. Information on suites availablethrough WCCV Meeting Services.

Individuals attending the World Cornea Congress V Meeting and the ASCRS•ASOA Symposiumand Congress should make only one hotel reservation for both meetings.

DEADLINE:March 15, 2005

Important

To attend the 2005 WCCV,you must complete a

registration form.

You must register forthe meeting to reserve

a hotel room.

To reserve hotel room

fwww.corneasociety.org

FAX: dDomestic:

(877) 878-3388International:

(514) 228-3087

eMail Check (payable to WCCV)or VISA/MasterCard/American

Express payment to:

WCCVMeeting Services

c/o Laser Registration1200 G St. NW, #800

Washington, DC 20005-3967

bAgents are available to

answer questions duringregular business hours

8:30 am to 6:00 pm EST

Domestic: (866) 614-5502

International: (514) 798-1932

E-mail:[email protected]

Names of allroom occupants: ____________________ ______________________

____________________ ______________________

Hotel PreferencePreferences assigned in order received. If requested rate is notavailable, the next available rate will be assigned.

1st ________________________ 2nd _________________________3rd ________________________ 4th _________________________5th ________________________ 6th _________________________Should my hotel preferences be unavailable at the time my registrationrequest is received, I understand WCCV Meeting Services will assign anavailable official hotel based on the range of hotel rates originallyrequested.

ReservationsAll reservations require a valid credit card number. See page 12 forinstructions.Charge to: ❑ a ❑ c ❑ d

Account Number Expiration date

Cardholder’s Name

Cardholder’s Signature

H O T E L R E S E R V A T I O N F O R M

Special Requirements:❑ Smoking Room q Special Assistance❑ Low Floor ❑ Other __________________ARRIVAL DATE DEPARTURE DATE

Type ofAccommodations❑ Single1 Person-1 Bed

❑ Double2 People-1 Bed

❑ Double/Double2 People-2 Beds

❑ Triple3 People-2 Dbl Beds

❑ Quad4 People-2 Dbl Beds

❑ Suite❑ 1 or ❑ 2 BedroomNo. of persons:_________________

Page 15: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

14

12. JW Marriott Hotel13. Madison Hotel14. Marriott at Metro Center15. Mayflower Hotel16. Morrison-Clark Inn17. Renaissance Washington DC18. Ritz Carlton19. St. Regis Washington DC20. Washington Plaza21. Washington Terrace Hotel22. Wyndham Washington DC

1. Beacon Hotel and Corporate Quarters2. Comfort Inn Convention Center3. Fairmont Hotel4. Four Points Sheraton5. Grand Hyatt Washington6. Hamilton Crowne Plaza7. Hampton Inn8. Hay Adams Hotel9. Henley Park

10. Holiday Inn Downtown11. Hotel Helix

M A P O F O F F I C A L H O T E L S

Page 16: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

15

Attendee FeeIncludes badge, printed program, all sessionsand the Thursday, April 14, reception at theLibrary of Congress in Washington, DC.

Spouse FeeIncludes badge, program, and the WorldCornea Congress V Reception, Thursday,April 14, at the Library of Congress inWashington, DC. Physicians cannot registerin this category. Entrance into sessions is notpermitted.

Payment a c

Registrations received with no payment willnot be processed.

Payment (in U.S. funds) can be made bypersonal check, bank draft, travelers check,VISA, or MasterCard.

Registration Categories■ Joint World Cornea Congress (WCCV)

and ASCRS Symposium registrants: Feeincludes entrance into WCCV meetingbeing held April 13–15, 2005 at the GrandHyatt Hotel and ASCRS•ASOA Symposium& Congress being held April 15–20, 2005,Washington Convention Center.

■ Cornea Society Member: MD or PhD whois a member in good standing with theCornea Society. Registration fee does notinclude membership dues.

■ Resident/Fellow/Trainee: An MD who isin a residency program. Verification ofresident/fellowship must be included withregistration and be on letterhead fromyour department chairperson or fellowshipsponsor. All letters must be verified duringand after the meeting.

To register Online

fwww.corneasociety.org

dDomestic:

(877) 878-3388International:

(514) 228-3087

eMail check (payable to WCCV)

or VISA/MasterCardpayment to:

WCCVc/o Laser Registration1200 G St. NW, #800

Washington, DC 20005-3967

bAgents are available to

answer questions duringregular business hours

8:30 am to 6:00 pm EST

Domestic: (866) 614-5502

International: (514) 798-1932

E-mail:[email protected]

■ Corporate/Other: Manufacturers who donot have exhibit space but wish to attendthe meeting. NO solicitation is permitted.

■ Spouse: Spouse of registered attendeewho is not a member or potential memberor corporate personnel. Does not includeentrance into sessions. Physicians can notregister in this category.

■ Press: Working members of the generalor ophthalmic press should contactJohn Ciccone at (703) 591-2220 [email protected] for complimentaryregistration.

PresentersAll presenters are required to register andpay an attendee fee for the meeting.

Advance Badge MailingBadges will be mailed to all attendees whopreregister by March 11, 2005. Badges forthose who preregister after this date must bepicked up on site at the Washington Conven-tion Center.

Cancellation/Refund PolicyAll cancellations and requests for refundsmust be in writing and received no later thanMarch 11, 2005. A handling fee of $125 willbe deducted from each canceled registration.The membership portion of the New/Renewregistration fee is nonrefundable. NOREFUNDS will be given after March 11,2005 There will be no exceptions to the EarlyBird deadline.

R E G I S T R A T I O N I N F O R M A T I O N

Fax

Questions?

Page 17: WCCV 2005: WASHINGTON, DC · of the Role of Inflammation in Ocular Surface Disease Stephen C. Pflugfelder, MD PRESENTATIONS Classification of Ocular Surface Disease Mark J. Mannis,

World Cornea Congress V Preview Program

16

Check ONE REGISTRATION FEE under appropriate column. Before 3/7 After 3/7 and On Site

World Cornea Congress V●20 Cornea Society Members: MD or PhD who is a member in good ❏ $450 ❏ $505standing with the Cornea Society. Registration fee does not includemembership dues.

●21 Cornea Society Non-members ❏ $500 ❏ $575

●22 Resident/Fellow/Trainee: An MD who is in a residency program. ❏ $250 ❏ $305Verification of resident/fellowship must be included with registrationand be on letterhead from your department chairperson or fellowshipsponsor. All letters must be verified during and after the meeting.

●23 Corporate/Other: Manufacturers who do not have exhibit space but ❏ $575 ❏ $655wish to attend the meeting. NO solicitation is permitted.

●24 Spouse/Guest: Spouse of registered attendee who is not a member, ❏ $75 ❏ $75potential member or corporate personnel. Does not include entrance intosessions. Physicians can not register in this category.

Register for Both Meetings and Save!Joint World Cornea Congress (WCCV) and ASCRS

Symposium•ASOA Congress●10 ASCRS and/or Cornea Society Members: Fee includes entrance into ❏ $920 ❏ $1330WCCV meeting being held April 13–15, 2005 at the Grand Hyatt Hotel andASCRS•ASOA Symposium & Congress being held April 15–20, 2005,Washington Convention Center.Resident/Fellow/Trainee: An MD who is in a residency program. Verification of resident/fellowship mustbe included with registration and be on letterhead from your department chairperson or fellowship sponsor.All letters must be verified during and after the meeting.

●11 Resident/Fellow DOMESTIC ❏ $285 ❏ $385

●12 Resident/Fellow INTERNATIONAL ❏ $455 ❏ $555

●13 Corporate/Other ❏ $1400 ❏ $1850

●14 Spouse/Guest ❏ $225 ❏ $275

Early Bird Deadline: March 7, 2005ONE registration per form. Copy form if necessary.

PaymentPayment (in U.S. funds only) can bemade by check, bank draft, travelerscheck, or VISA/MasterCard. Paymentmust accompany registration.

f Register online atwww.corneasociety.org

d FaxDomestic: (877) 878-3388International: (514) 228-3087

e WCCVc/o Laser Registration1200 G St, NW # 800Washington, DC 20005-3967

NOTE: Please allow 5–7 businessdays for registration to be processed.If you do not receive confirmation,please contact us. Registrations will beconfirmed by e-mail, facsimile, or mail.

WCCV is hereby authorized toadjust registration and attendancecharges originally paid via fax,phone, or Internet using mycredit card if the amountoriginally paid was deficient orexcessive by charging orcrediting my credit card accountand providing a mailed notice ofthe adjustment.

Payment MethodTOTAL AMOUNT ENCLOSED $ _________(in U.S. Funds)❏ Check Enclosed (Payable to WCCV)Charge to ❏ a ❏ c

ACCOUNT NUMBER

EXPIRATION DATE

Cardholder’s Name (please print)

Cardholder’s Signature

Cancellation/Refund PolicyDEADLINE: March 11, 2005All cancellations and requests forrefunds must be in writing andreceived no later than March 11, 2005.A handling fee of $125.00 will bededucted from each cancelledregistration. NO REFUNDS will begiven after March 11, 2005.

WCCV is ADA compliant. Any registrantwho requires special accommodationsshould contact WCCV by March 11, 2005:(703) 591-0196

LAST/FAMILY NAME FIRST NAME MI DEGREE

PRACTICE NAME

BUSINESS MAILING ADDRESS

BUSINESS MAILING ADDRESS

CITY STATE ZIP COUNTRY

BUSINESS TELEPHONE (International Attendees, please FACSIMILEInclude city and country code for phone and fax)

E-MAIL ADDRESS

Are you: ❏ MD ❏ Fellow/Resident ❏ Other

Questions?b Domestic: (866) 614-5502

International: (514) 798-1932Mon.–Fri. 8:30 AM to 6:00 PM EST

R E G I S T R A T I O N F O R M